| Pharmaceutical Information |
| Drug Name |
Malathion |
| Drug ID |
BADD_D01346 |
| Description |
Malathion is a parasympathomimetic organophosphate compound that is used as an insecticide for the treatment of head lice. Malathion is an irreversible cholinesterase inhibitor and has low human toxicity. |
| Indications and Usage |
For patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair. |
| Marketing Status |
approved; investigational |
| ATC Code |
P03AX03 |
| DrugBank ID |
DB00772
|
| KEGG ID |
D00534
|
| MeSH ID |
D008294
|
| PubChem ID |
4004
|
| TTD Drug ID |
D0K3LW
|
| NDC Product Code |
51672-5293; 68022-0001; 51672-5294 |
| UNII |
U5N7SU872W
|
| Synonyms |
Malathion | Karbofos | Carbophos | Carbafos | Carbofos | Prioderm | Sadophos | Cythion |
|
| Chemical Information |
| Molecular Formula |
C10H19O6PS2 |
| CAS Registry Number |
121-75-5 |
| SMILES |
CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
